Psychotropic Drug Use in Pregnancy

Abstract

purpose of this chapter is (1) to review the course of certain psychiatric illnesses in pregnancy, (2) to describe the putative risks of specific psychotropic drug use in pregnancy, and (3) to provide the clinician with an approach to assessing the risks and benefits of treating psychiatrically ill pregnant patients and for choosing and instituting therapy with these agents assessment of the pregnant psychiatric patient [risks of pharmacotherapy, risks associated with psychiatric illness, assessing risk versus benefit] / course and management of psychiatric illness in pregnancy [psychosis, antipsychotics] / unipolar and bipolar mood disorders [antidepressants and monoamine oxidase inhibitors, lithium, electroconvulsive therapy] / anxiety disorders and benzodiazepines / breast feeding (PsycINFO Database Record (c) 2019 APA, all rights reserved) (Source: chapter)